John Kerr posted in cancer • funding • keytruda • melanoma • pharmac • pharmaceuticals • politics • public health on March 1st, 2016.
Public pressure is growing for the Government to fund the melanoma drug Keytruda, listed as ‘low priority’ by drug funding agency PHARMAC. A petition of over 45,000 signatures, calling for the drug to be funded through PHARMAC, is due to be presented to Health Minister Jonathan Coleman on the steps of parliament today. Speaking to […]
Continue reading “Push for Keytruda funding – Expert reaction”